Suppr超能文献

应激期间或给予5-羟色氨酸后排便增加:5-HT(4)受体拮抗剂SB-207266的选择性抑制作用

Increased defecation during stress or after 5-hydroxytryptophan: selective inhibition by the 5-HT(4) receptor antagonist, SB-207266.

作者信息

Sanger G J, Yoshida M, Yahyah M, Kitazumi K

机构信息

Department of Neuroscience Research, SmithKline Beecham Pharmaceuticals, Third Avenue, Harlow, Essex, CM19 5AW.

出版信息

Br J Pharmacol. 2000 Jun;130(3):706-12. doi: 10.1038/sj.bjp.0703367.

Abstract

5-HT(4) receptor antagonism prevents the ability of exogenous 5-HT or 5-HTP to sensitize the intestinal peristaltic reflex and increase the rate of defecation, generally without affecting non-stimulated intestinal function. In this study we confirmed the ability of the selective 5-HT(4) receptor antagonist SB-207266 1 - 1000 microg kg(-1) p.o., to prevent the increase in defecation evoked over a 60 min period by 5-HTP 10 mg kg(-1) s.c. in conscious mice, in the absence of an apparent constipating action. The role of endogenous 5-HT in the mechanisms of increased defecation and/or diarrhoea was then investigated in conscious, fed rats. This was evoked by 180 min exposure to restraint stress, which increased both the number and mean weight of formed, faecal pellets excreted over the entire time period. SB-207266 1 - 1000 microg kg(-1) p.o. (dosed 30 min before restraint) did not affect the increase in defecation evoked during the first 60 min of restraint stress, but significantly and dose-dependently reduced or prevented the increased defecation during the remaining 120 min of the experiment; this action occurred in the absence of an apparent constipating action of SB-207266. In fasted rats exposed to restraint stress, watery diarrhoea developed and although there was a tendency for SB-207266 1 - 1000 microg kg(-1) p.o. (dosed 30 min before restraint) to reduce the incidence of diarrhoea, this inhibition was not complete. We conclude that selective 5-HT(4) receptor antagonism prevents disruptions in defecation behaviours caused by exogenous or endogenous enteric 5-HT and that this activity is not accompanied by a concomitant suppression of activity (constipation-like) within the intestine itself.

摘要

5-羟色胺(5-HT)(4)受体拮抗作用可阻止外源性5-羟色胺或5-羟色胺酸(5-HTP)使肠道蠕动反射敏感化并增加排便率的能力,一般不会影响未受刺激的肠道功能。在本研究中,我们证实了选择性5-HT(4)受体拮抗剂SB - 207266以1 - 1000微克/千克口服给药,可防止清醒小鼠皮下注射10毫克/千克5-HTP在60分钟内引起的排便增加,且无明显的致便秘作用。然后在清醒的进食大鼠中研究内源性5-羟色胺在排便增加和/或腹泻机制中的作用。这是通过180分钟的束缚应激诱发的,束缚应激增加了整个时间段内排出的成形粪便颗粒的数量和平均重量。SB - 207266以1 - 1000微克/千克口服给药(在束缚前30分钟给药)不影响束缚应激最初60分钟内诱发的排便增加,但在实验剩余的120分钟内显著且剂量依赖性地减少或阻止了排便增加;此作用在SB - 207266无明显致便秘作用的情况下发生。在禁食大鼠中施加束缚应激会出现水样腹泻,尽管SB - 207266以1 - 1000微克/千克口服给药(在束缚前30分钟给药)有降低腹泻发生率的趋势,但这种抑制并不完全。我们得出结论,选择性5-HT(4)受体拮抗作用可防止由外源性或内源性肠5-羟色胺引起的排便行为紊乱,且这种活性不会伴随着肠道自身活动的同时抑制(类似便秘)。

相似文献

2
Increased defaecation caused by 5-HT4 receptor activation in the mouse.
Eur J Pharmacol. 1996 Jul 18;308(2):181-6. doi: 10.1016/0014-2999(96)00296-8.

引用本文的文献

2

本文引用的文献

9
Serotonergic involvement in stress-induced ACTH release.
Brain Res. 1998 Nov 16;811(1-2):10-20. doi: 10.1016/s0006-8993(98)00901-9.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验